[ad_1] The study project which aims to identify the "marker" or "set of markers" capable of accurately predicting the conversion of the diagnosis of mild cognitive impairment (MCI) into a disease of …
Read More »Access to innovative medicines. From AIFA inclusion and new treatment opportunities
[ad_1] The Agency has adopted, especially in recent years, a policy of inclusion and openness, as evidenced by the expanding criteria for access to new drugs against Hepatitis C and the increase …
Read More »Valsartan, here are the lots removed by the Italian Medicines Agency (AIFA)
[ad_1] The Italian Medicines Agency ordered the removal of several batches of drugs based on the active substance Valsartan . Indeed, a quality defect was found which, as a precaution, was ordered …
Read More »AIFA: here are the new regional nominations for the Scientific Technical Advisory Commission and the Awards and Reimbursement Committee
[ad_1] Representatives are selected "from persons with proven technical and scientific expertise and documented for at least five years in the field of drug evaluation". The members of the Awards and Reimbursement …
Read More »Vaccines, AIFA data on reactions: "Not serious in 8 out of 10 cases"
[ad_1] There are more reports of adverse events caused by vaccines, but 80% are "not serious" as in previous years. The Italian pharmaceutical agency AIFA discloses the 2017 pharmacovigilance data, based on …
Read More »Hypertension, AIFA makes arrangements for withdrawal of many different drugs
[ad_1] The Italian Medicines Agency ordered the removal of several batches of drugs based on the active substance valsartan. Indeed, a quality defect was found, that, as a precautionary measure, AIFA and …
Read More »Aifa, 700 Lotti di farmación per ipertensione ritirati da commercio
[ad_1] The Agenzia Italiana del Farmaco (Aifa) and the commercial land of 700 lotti di farmación per ipertensione basati sul principio attivo del valsartan : if tratta di a rimedio to fight …
Read More »Aifa removes different drugs with valsartan
[ad_1] The Italian Medicines Agency ordered the removal of several batches of media based on the active substance valsartan. The decision was made because of some impurities that occurred during its production …
Read More »Aifa has available withdrawal from pharmacies of different packs of valsartan-based medicines for a quality defect. They are used for hypertension and after a heart attack
[ad_1] The withdrawal also in the rest of Europe. The drugs based on valsartan are used for the treatment of high blood pressure and heart failure and in patients who have suffered …
Read More »